文献速递关节外科

双动关节在翻修全髋关节置换术中的应用:与金属或陶瓷头配高交联聚乙烯及限制性关节的比较

Dual-Mobility Articulations in Revision Total Hip Arthroplasty: A Comparison with Metal or Ceramic on Highly Cross-Linked Polyethylene and Constrained Articulations.
PubMed 文献 · J Bone Joint Surg Am · 2024-10-17

基于美国整合医疗系统全关节置换登记数据的队列研究,纳入2002至2022年因无菌性原因行翻修全髋关节置换术的成人患者,比较双动髋臼假体与限制性内衬、金属或陶瓷单极股骨头配高交联聚乙烯的再翻修和脱位风险。调整混杂因素后,双动假体组的再翻修和脱位风险最低。

要点

  • 双动假体使用率从2011年的1.0%上升至2022年的21.6%。
  • 与双动组相比,限制性内衬组再翻修风险更高(HR=2.43)。
  • 与双动组相比,高交联聚乙烯两组脱位风险均更高(HR分别为2.04和2.46)。

核心结论

  • 在美国大型队列中,使用双动假体的翻修全髋关节置换术再翻修风险和脱位风险最低。
  • 再翻修风险显著低于限制性内衬和单极股骨头配高交联聚乙烯,脱位风险显著低于单极股骨头配高交联聚乙烯,脱位风险有低于限制性内衬的趋势但未达统计学显著。

研究设计与样本

  • 队列研究,使用美国整合医疗系统全关节置换登记数据。
  • 纳入2002至2022年行初次全髋关节置换术后因无菌性原因行翻修全髋关节置换术的成人患者。
  • 翻修时使用双动假体375例、限制性内衬268例、小于36 mm头配高交联聚乙烯995例、大于等于36 mm头配高交联聚乙烯2087例。
  • 采用多变量Cox比例风险回归评估结局,并调整患者、手术和术者混杂因素。

主要发现

  • 双动假体使用率从2011年的1.0%上升至2022年的21.6%。
  • 与双动组相比,限制性内衬组再翻修风险更高(HR=2.43,95%CI=1.29至4.59)。
  • 与双动组相比,小于36 mm头配高交联聚乙烯组再翻修风险更高(HR=2.05,95%CI=1.13至3.75)。
  • 与双动组相比,大于等于36 mm头配高交联聚乙烯组再翻修风险更高(HR=2.03,95%CI=1.19至3.48)。
  • 与双动组相比,小于36 mm头配高交联聚乙烯组脱位风险更高(HR=2.04,95%CI=1.33至3.14),大于等于36 mm头配高交联聚乙烯组脱位风险更高(HR=2.46,95%CI=1.69至3.57)。

关键数值与推荐

  • 与双动组相比,限制性内衬组再翻修HR=2.43(95%CI=1.29至4.59)。
  • 与双动组相比,小于36 mm头配高交联聚乙烯组再翻修HR=2.05(95%CI=1.13至3.75),脱位HR=2.04(95%CI=1.33至3.14)。
  • 与双动组相比,大于等于36 mm头配高交联聚乙烯组再翻修HR=2.03(95%CI=1.19至3.48),脱位HR=2.46(95%CI=1.69至3.57)。
  • 限制性内衬组与双动组相比,脱位风险有更高的趋势但未达统计学显著。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The increased availability of dual-mobility acetabular constructs (DMCs) provides surgeons with a newer option to increase the effective femoral head size in revision total hip arthroplasty (rTHA). We sought to evaluate risks of re-revision and prosthetic dislocation following rTHA involving a DMC compared with other articulations. METHODS: A cohort study was conducted using data from a U.S. integrated health-care system's Total Joint Replacement Registry. Adult patients who underwent primary THA and went on to undergo an aseptic rTHA in 2002 to 2022 were identified. Patients who received a DMC, a constrained liner, or a metal or ceramic unipolar femoral head on highly cross-linked polyethylene (XLPE) at the time of rTHA were the treatment groups. Subsequent aseptic re-revision and dislocation were the outcomes of interest. Multivariable Cox proportional-hazards regression was used to evaluate the risks of the outcomes, with adjustment for patient, operative, and surgeon confounders. RESULTS: The analyzed rTHAs comprised 375 with a DMC, 268 with a constrained liner, 995 with a <36-mm head on XLPE, and 2,087 with a ≥36-mm head on XLPE. DMC utilization increased from 1.0% of rTHAs in 2011 to 21.6% in 2022. In adjusted analyses, a higher re-revision risk was observed for the constrained liner (hazard ratio [HR] = 2.43, 95% confidence interval [CI] = 1.29 to 4.59), <36 mm on XLPE (HR = 2.05, 95% CI = 1.13 to 3.75), and ≥36 mm on XLPE (HR = 2.03, 95% CI = 1.19 to 3.48) groups compared with the DMC group. A higher dislocation risk was observed in both XLPE groups (<36 mm: HR = 2.04, 95% CI = 1.33 to 3.14; ≥36 mm: HR = 2.46, 95% CI = 1.69 to 3.57) compared with the DMC group; a nonsignificant trend toward a higher dislocation rate in the group with a constrained liner than in the DMC group was also observed. CONCLUSIONS: In a large U.S.-based cohort, rTHAs using DMCs had the lowest re-revision risk and dislocation risk. Both outcomes were significantly lower than those using a unipolar femoral head on XLPE, re-revision risk was significantly lower than using a constrained liner, and dislocation risk trended toward a lower risk than using a constrained liner. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Khatod M, Chan PH, Prentice HA, et al. Dual-Mobility Articulations in Revision Total Hip Arthroplasty: A Comparison with Metal or Ceramic on Highly Cross-Linked Polyethylene and Constrained Articulations. J Bone Joint Surg Am. 2024. PMID: 39418353. doi:10.2106/JBJS.24.00168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。